This disclosure relates to approaches for controlling the unloading stress of Nitinol devices, and/or other shape memory material devices, in order to facilitate healing of diseased or damaged tissue. The present disclosure finds particular utility in the field of orthopedics, and specifically as an approach for creating and using devices for reducing fractures and generating and maintaining compression between bone fragments. While the present disclosure has application throughout the body, its utility will sometimes hereinafter be illustrated in the context of providing and using screws, staples, plates, and/or intramedullary devices for the repair of fractured or displaced bone tissue.
In the field of orthopedic surgery, it is common to rejoin broken bones. The success of the surgical procedure often depends on the ability to reapproximate the fractured bone, the amount of compression achieved between the bone fragments, and the ability to sustain that compression over a period of time. If the surgeon is unable to bring the bone fragments into close contact, a gap will exist between the bone fragments and the bone tissue will need to first fill that gap before complete healing can take place. Furthermore, gaps between bone fragments that are too large can allow motion to occur between the fragments, disrupting the healing tissue and thus slowing the healing process. Thus, non-unions, mal-unions, and delayed-unions of fractures can occur when the gap between bone fragments is too large. Optimal healing requires that the bone fragments be in close contact with each other, and for a compressive load to be applied and maintained between the bone fragments. Compressive strain between bone fragments has been found to accelerate the healing process in accordance with Wolf's Law.
Broken bones can be rejoined using screws, staples, plates, intramedullary devices, and other devices known in the art. These devices are designed to assist the surgeon with reducing the fracture and creating a compressive load between the bone fragments.
Screws are typically manufactured from either titanium or stainless steel alloys and may be lag screws or headless screws. Lag screws have a distal threaded region and an enlarged head. The head contacts the cortical bone surface and the action of the threaded region reduces the fracture and generates a compressive load. Headless screws typically have a threaded proximal region and a threaded distal region. A differential in the thread pitch of the two regions generates compression across the fracture site. There also exist fully-threaded headless compression screws that have a thread pitch which differs over the length of the single continuous thread.
Staples are formed from a plurality of legs (typically two legs, although sometimes more than two legs may be provided) connected together by a bridge. Staples are typically manufactured from stainless steel alloys, titanium alloys, or Nitinol, a shape memory alloy. The staples are inserted into pre-drilled holes on either side of the fracture site.
Plates are also used to rejoin broken bones. These plates are generally formed from a sheet or ribbon of material having a plurality of holes formed therein. The plates are typically manufactured from either stainless steel alloys or titanium alloys. The plates are placed adjacent to a fracture so that the plate spans the fracture line, and then screws are inserted through the holes in the plate and into the bone fragments on either side of the fracture site to stabilize the bone fragments relative to one another.
Intramedullary devices are often used for fractures of the long bones; however, they are also frequently used in the phalanges, and specifically for the treatment of “hammer toe”, which is a deformity of the proximal interphalangeal joint of the second, third, or fourth toe causing the toe to be permanently bent, e.g., bent upwards. Typical intramedullary devices used in the phalanges have opposing ends that are adapted to grip the interior wall of the intramedullary canal. These intramedullary devices are typically made of titanium alloys, stainless steel alloys, Nitinol and/or other materials, e.g., PEEK. The titanium alloy devices and stainless steel alloy devices often have barbs or threaded regions at their opposing ends to grip the interior wall of the intramedullary canal. The Nitinol devices may have a pair of radially-extending “legs” at their opposing ends that expand outward when warmed to body temperature, with the pair of legs at each end of the device being disposed in a common plane.
While the foregoing devices (e.g., screws, staples, plates, and intramedullary devices) are designed to bring the bone fragments into close contact and to generate a compressive load between the bone fragments, the devices do not always succeed in accomplishing this objective. It is widely reported that the compressive load generated by these devices between the bone fragments dissipates rapidly as the bone relaxes and remodels around the device.
Nitinol can be used to improve the functional performance of these devices by utilizing either the shape memory effect of Nitinol or the superelastic properties of Nitinol to pull together the opposing bone fragments; however, the recovery forces and recoverable strain generated by the Nitinol versions of these devices may be too great and may damage bone tissue and thus not provide a means to generate and maintain compression between the bone fragments.
Thus there exists a clinical need for device that can be used to control the unloading stress and recoverable strain of Nitinol devices, and/or other shape memory material devices, so as to allow for devices that are able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs without damaging the bone tissue.
This disclosure provides novel devices for controlling the unloading stress and recoverable strain of Nitinol devices/implants and/or other shape memory material devices/implants. The devices may be used to bring bone fragments into close proximity with each other, generate a compressive load between the bone fragments, and maintain that compressive load between the bone fragments while healing occurs.
In an embodiment, a device is provided for controlling the recoverable strain and compression generated by a Nitinol staple. The device allows the surgeon to control to what extent the legs of the staple are opened to or beyond the parallel state. The more the staple is opened, the more recoverable strain and compression the staple will exert on the bone. This device is also beneficial because it allows the surgeon to control the rate of loading the compression onto the bone, and also provides a feedback for the surgeon to feel how much compression the bone is experiencing.
In another embodiment, a device is provided for controlling the recoverable strain and compression generated by a Nitinol compression screw. The Nitinol compression screw is elongated and held in the elongated state with an internal retaining pin. It may be provided to the surgeon with the screw stretched to the maximum (˜8%). The surgeon can partially withdraw the internal retaining pin to decrease the compressive force and recoverable strain the screw will exert on the bone following implantation. The more the internal retaining pin is removed, the less recoverable stress and strain the screw will exert. This is beneficial because it allows the surgeon to have better control of the device, and may be especially beneficial for the treatment of low density bone fractures.
In another embodiment, a device is provided for controlling the recoverable strain and compression generated by a Nitinol compression plate. The Nitinol compression plate is elongated and held in the elongated state with a delivery device. It may be provided to the surgeon with the plate fully elongated. The surgeon can use the delivery device to allow for partial stress/strain recovery of the device prior to implantation. This is beneficial because it allows the surgeon to have better control of the device, and may be especially beneficial for the treatment of low density bone fractures.
In yet another embodiment, a device is provided for controlling the recoverable strain and compression generated by a Nitinol intramedullary implant. The Nitinol intramedullary implant is provided in an elongated state with an internal retaining pin. The surgeon can partially withdraw the internal retaining pin to decrease the compressive force and recoverable strain the intramedullary implant will exert on the bone following implantation. The more the internal retaining pin is removed, the less recoverable stress and strain the intramedullary implant will exert. This is beneficial because it allows the surgeon to have better control of the device, and may be especially beneficial for the treatment of low density bone fractures.
The various features and advantages of this disclosure will become apparent to those skilled in the art from the following detailed description. The drawings that accompany the detailed description can be briefly described as follows.
A method for controlling an unloading stress of an orthopedic implant according to an exemplary aspect of this disclosure includes, inter alia, positioning an implant made of a shape memory material in a deformed state to generate a stress level and recoverable strain within the implant, holding the implant in the deformed state with a retaining mechanism, and adjusting the retaining mechanism to control a level of deformation of the implant and alter the stress level and recoverable strain of the implant.
In a further embodiment, an implant is a compression screw.
In a further embodiment, a compression screw is made of Nitinol.
In a further embodiment, an implant is a compression staple.
In a further embodiment, a compression screw is made of Nitinol.
In a further embodiment, an implant is a compression plate.
In a further embodiment, a compression plate is made of Nitinol.
In a further embodiment, an implant is an intramedullary implant.
In a further embodiment, an intramedullary implant is made of Nitinol.
In a further embodiment, positioning an implant in a deformed state includes using superelastic or shape memory properties of the implant.
In a further embodiment, a retaining mechanism is a delivery device.
In a further embodiment, a delivery device includes a plunger.
In a further embodiment, a retaining mechanism is an internal retaining pin.
In a further embodiment, adjusting a retaining mechanism includes advancing a plunger to spread legs of an implant apart.
In a further embodiment, adjusting a retaining mechanism includes partially unscrewing an internal retaining pin from a central hollow region of an implant.
In a further embodiment, adjusting a retaining mechanism includes moving a restraining clip to change an amount that a central bridge of an implant bows outward.
In a further embodiment, at least a portion of an implant is reversibly stretched prior to holding the implant with a retaining mechanism.
In a further embodiment, an unloading stress of an implant is controlled with a retaining mechanism during implantation of the implant into bone.
A method according to another exemplary aspect of this disclosure includes, inter alia, positioning an implant made of a shape memory material in a deformed state to generate a stress level and recoverable strain within the implant, adjusting a level of deformation of the implant to alter the stress level and recoverable strain of the implant, and implanting the implant into bone, wherein the implant exerts a compressive load on the bone that is proportional to the stress level and recoverable strain generated in the implant while adjusting the level of deformation
Referring first to
Referring next to
Referring now to
The foregoing description shall be interpreted as illustrative and not in any limiting sense. A worker of ordinary skill in the art would recognize that certain modifications could come within the scope of this disclosure. For these reasons, the following claims should be studied to determine the true scope and content of this disclosure.
This application claims priority to U.S. Provisional Application No. 62/238,472, which was filed on Oct. 7, 2015, the disclosure of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
6093188 | Murray | Jul 2000 | A |
6325805 | Ogilvie et al. | Dec 2001 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6626937 | Cox | Sep 2003 | B1 |
6656181 | Dixon et al. | Dec 2003 | B2 |
6773437 | Ogilvie et al. | Aug 2004 | B2 |
7172593 | Trieu et al. | Feb 2007 | B2 |
7309340 | Fallin et al. | Dec 2007 | B2 |
7479143 | Suh et al. | Jan 2009 | B2 |
7618441 | Groiso | Nov 2009 | B2 |
7655009 | Grusin | Feb 2010 | B2 |
7699879 | Sherman et al. | Apr 2010 | B2 |
7763056 | Dalton | Jul 2010 | B2 |
7771457 | Kay et al. | Aug 2010 | B2 |
7875070 | Molaei | Jan 2011 | B2 |
7976648 | Boylan et al. | Jul 2011 | B1 |
7985222 | Gall et al. | Jul 2011 | B2 |
7993380 | Hawkes | Aug 2011 | B2 |
8048134 | Partin | Nov 2011 | B2 |
8062378 | Fonte | Nov 2011 | B2 |
8080044 | Biedermann et al. | Dec 2011 | B2 |
8118952 | Gall et al. | Feb 2012 | B2 |
8216398 | Bledsoe et al. | Jul 2012 | B2 |
8257404 | Hack | Sep 2012 | B2 |
8262659 | Ryan et al. | Sep 2012 | B2 |
8394097 | Peyrot et al. | Mar 2013 | B2 |
8419797 | Biedermann et al. | Apr 2013 | B2 |
8425588 | Molaei | Apr 2013 | B2 |
8439916 | Coati et al. | May 2013 | B2 |
8460293 | Coati et al. | Jun 2013 | B2 |
8475457 | Shano | Jul 2013 | B2 |
8584853 | Knight et al. | Nov 2013 | B2 |
8623061 | Quevedo et al. | Jan 2014 | B2 |
8715325 | Weiner et al. | May 2014 | B2 |
8721646 | Fox | May 2014 | B2 |
8740954 | Ghobrial et al. | Jun 2014 | B2 |
8784459 | Kaufman et al. | Jul 2014 | B2 |
8808294 | Fox et al. | Aug 2014 | B2 |
8834483 | Cheney et al. | Sep 2014 | B2 |
8858603 | Zufelt | Oct 2014 | B1 |
8864804 | Champagne et al. | Oct 2014 | B2 |
8888826 | Kinmon et al. | Nov 2014 | B2 |
8894669 | Nering et al. | Nov 2014 | B2 |
8998999 | Lewis et al. | Apr 2015 | B2 |
9017331 | Fox | Apr 2015 | B2 |
9044281 | Pool et al. | Jun 2015 | B2 |
9050153 | Luxon et al. | Jun 2015 | B2 |
9056014 | McCormick et al. | Jun 2015 | B2 |
9072562 | Weiner et al. | Jul 2015 | B2 |
9078718 | Campbell | Jul 2015 | B2 |
9095338 | Taylor et al. | Aug 2015 | B2 |
9101349 | Knight et al. | Aug 2015 | B2 |
9119681 | Kaufmann et al. | Sep 2015 | B2 |
9168147 | Patterson et al. | Oct 2015 | B2 |
9204932 | Knight et al. | Dec 2015 | B2 |
9241738 | Quevedo et al. | Jan 2016 | B2 |
9254350 | Udipi et al. | Feb 2016 | B2 |
9265531 | Ziolo | Feb 2016 | B2 |
9282977 | Penzimer et al. | Mar 2016 | B2 |
9308035 | Biedermann et al. | Apr 2016 | B2 |
9326794 | Harms et al. | May 2016 | B2 |
9326804 | Biedermann et al. | May 2016 | B2 |
9339268 | Fox | May 2016 | B2 |
9339316 | Hulliger | May 2016 | B2 |
9408647 | Cheney | Aug 2016 | B2 |
9451955 | Fox | Sep 2016 | B2 |
9451957 | Fox | Sep 2016 | B2 |
9861413 | Palmer | Jan 2018 | B2 |
20050085814 | Sherman et al. | Apr 2005 | A1 |
20050136764 | Sherman et al. | Jun 2005 | A1 |
20050165394 | Boyce et al. | Jul 2005 | A1 |
20050187555 | Biedermann et al. | Aug 2005 | A1 |
20050240190 | Gall et al. | Oct 2005 | A1 |
20060235405 | Hawkes | Oct 2006 | A1 |
20060264954 | Sweeney | Nov 2006 | A1 |
20070198017 | Tschakaloff et al. | Aug 2007 | A1 |
20080039847 | Piper et al. | Feb 2008 | A1 |
20080097443 | Campbell | Apr 2008 | A1 |
20080215097 | Ensign | Sep 2008 | A1 |
20080243264 | Fonte | Oct 2008 | A1 |
20080262629 | Fonte | Oct 2008 | A1 |
20090125071 | Skinlo et al. | May 2009 | A1 |
20090164016 | Georgy et al. | Jun 2009 | A1 |
20090198287 | Chiu | Aug 2009 | A1 |
20090216334 | Leibel | Aug 2009 | A1 |
20100076498 | Tyber et al. | Mar 2010 | A1 |
20100121329 | Ryan et al. | May 2010 | A1 |
20100131014 | Peyrot et al. | May 2010 | A1 |
20100211115 | Tyber | Aug 2010 | A1 |
20100241120 | Bledsoe et al. | Sep 2010 | A1 |
20110004255 | Weiner et al. | Jan 2011 | A1 |
20110066190 | Schaller et al. | Mar 2011 | A1 |
20110112579 | Brazil et al. | May 2011 | A1 |
20110190776 | Palmaz | Aug 2011 | A1 |
20120123554 | Fonte | May 2012 | A1 |
20120172876 | Coati et al. | Jul 2012 | A1 |
20120271363 | Luxon et al. | Oct 2012 | A1 |
20130030437 | Fox | Jan 2013 | A1 |
20130046346 | Thorwarth et al. | Feb 2013 | A1 |
20130060337 | Petersheim et al. | Mar 2013 | A1 |
20130123857 | Biedermann et al. | May 2013 | A1 |
20130123925 | Patterson et al. | May 2013 | A1 |
20130190817 | Bouduban | Jul 2013 | A1 |
20130206815 | Fox | Aug 2013 | A1 |
20130226241 | Thompson et al. | Aug 2013 | A1 |
20130274814 | Weiner et al. | Oct 2013 | A1 |
20130325074 | Ziolo | Dec 2013 | A1 |
20140014553 | Knight et al. | Jan 2014 | A1 |
20140018809 | Allen | Jan 2014 | A1 |
20140020333 | Knight et al. | Jan 2014 | A1 |
20140024002 | Knight et al. | Jan 2014 | A1 |
20140114311 | Pool et al. | Apr 2014 | A1 |
20140188237 | McCormick et al. | Jul 2014 | A1 |
20140257291 | Houff | Sep 2014 | A1 |
20140257420 | Fox | Sep 2014 | A1 |
20140277516 | Miller et al. | Sep 2014 | A1 |
20140330313 | Kaufman et al. | Nov 2014 | A1 |
20140336651 | Bouduban et al. | Nov 2014 | A1 |
20140336710 | Georgy | Nov 2014 | A1 |
20140358187 | Taber | Dec 2014 | A1 |
20140358247 | Fox et al. | Dec 2014 | A1 |
20150011998 | McCormick et al. | Jan 2015 | A1 |
20150080970 | Campbell et al. | Mar 2015 | A1 |
20150238237 | Madjarov | Aug 2015 | A1 |
20150238238 | Cheney | Aug 2015 | A1 |
20150245859 | McMillen et al. | Sep 2015 | A1 |
20150257804 | Baynham | Sep 2015 | A1 |
20150305789 | Weiner et al. | Oct 2015 | A1 |
20160051284 | Cronen | Feb 2016 | A1 |
20160095638 | Reimels | Apr 2016 | A1 |
20160135808 | Anderson | May 2016 | A1 |
Number | Date | Country | |
---|---|---|---|
20170100163 A1 | Apr 2017 | US |
Number | Date | Country | |
---|---|---|---|
62238472 | Oct 2015 | US |